Clinical Trial Update: A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants. [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing a new scopolamine transdermal patch to the reference patch in healthy adults to evaluate bioavailability and adhesion; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness

Drugs mentioned

• New scopolamine transdermal delivery system patch (scopolamine transdermal patch)
• Reference scopolamine transdermal delivery system patch (scopolamine transdermal patch)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Motion Sickness | Phase 1 | Status: COMPLETED